Skinvisible Pharmaceuticals, Inc. announced the forming of Kintari, a new wholly-owned subsidiary to market a premium line of scientifically formulated skin care products powered by the company’s patented Invisicare® technology. As part of the company’s strategic focus on revenue generation and creating shareholder value, Kintari will be a direct sales company that will launch products initially in the United States and Canada. The Kintari product portfolio consists of “Youth Renewed” (YR) anti-aging products to help fight the signs of aging. The Kintari YR product line will include a day and night cream. Additional products will be added to enhance this product line as the company grows and expands.
No comments yet. Be the first to comment!
Leave a Reply
0 Comments